The FDA has given Roche the go-ahead to market its Accu-Chek® Nano SmartView blood glucose monitoring system. The Nano, which uses Accu-Chek SmartView test strips, will be available to US consumers within the first half of this year. It is part of the same product line as the Accu-Chek Aviva Nano and Accu-Chek Performa Nano systems, which Roche has already launched in several overseas markets.
The meter, which Roche describes as smaller than a credit card, does not require coding or calibration. Other features include a large backlit display, customizable test reminders, pre- and post-meal markers, and average glucose calculations. According to Marc Gibeley, head of Roche Diabetes Care North America, “It is easy to use and will help people with diabetes regularly check their blood glucose levels before making informed therapy and lifestyle adjustments.”